Matches in SemOpenAlex for { <https://semopenalex.org/work/W2332491362> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2332491362 endingPage "S35" @default.
- W2332491362 startingPage "S35" @default.
- W2332491362 abstract "Acute myeloid leukemia (AML) is a malignant disorder of progenitor cells in myeloid hematopoiesis. The majority of AML patients achieve complete remission with the current therapeutic treatment but relapse frequently occurs which shortens survival of AML patients. The dismal cure rate of current therapeutic strategies stresses the urgent need of novel strategy to prevent relapse and lengthen the survival of AML patients. Therefore, DC based cancer immunotherapy presents as an attractive adjunct for the treatment of AML. We hypothesized that AML dendritic cell (DC)-based vaccine plus chemotherapy using cytosine arabinoside (AraC) induces better antitumor effect in AML mouse model. Therapeutic efficacy of syngeneic DC-based vaccine alone or in combination with chemotherapy in antitumor immunity was evaluated in vivo. Female C57BL/6 mice were challenged subcutaneously with murine C1498 AML cells and tumor bearing mice were treated as follows: 1) PBS injection; 2) cytosine arabinoside (AraC, 100 mg/kg) alone; 3) DC vaccine (2.0×106 cells/mouse) alone; 4) combination of AraC followed by DC vaccine (AraC-DC) treatment; and 5) DC vaccine followed by AraC and repeat DC injection (DC-AraC-DC). We found that individual treatments (DC vaccine or AraC treatment alone) induced only transient tumor regression with minimal survival advantage as compared to PBS control. The combinatorial therapy, both AraC-DC (P = 0.093) and DC-AraC-DC (P < 0.001) treatment, conferred greater tumor suppression effects and strongly prolonged median survival time of AML bearing mice (median survival 15 days & 20 days vs 10 days, respectively). The DC-AraC-DC treatment approach appears to be superior in increasing the tumor eradication as compared to AraC-DC treatment (P < 0.05). These findings raise the possibility of utilizing this approach to treat AML patients clinically." @default.
- W2332491362 created "2016-06-24" @default.
- W2332491362 creator A5040830222 @default.
- W2332491362 creator A5041059803 @default.
- W2332491362 creator A5051072518 @default.
- W2332491362 creator A5080878492 @default.
- W2332491362 creator A5086911541 @default.
- W2332491362 creator A5088771612 @default.
- W2332491362 date "2013-04-01" @default.
- W2332491362 modified "2023-09-25" @default.
- W2332491362 title "Combination therapy with dendritic cell-based vaccine and chemotherapy is active against acute myeloid leukemia in a mouse model" @default.
- W2332491362 doi "https://doi.org/10.1016/j.jcyt.2013.01.132" @default.
- W2332491362 hasPublicationYear "2013" @default.
- W2332491362 type Work @default.
- W2332491362 sameAs 2332491362 @default.
- W2332491362 citedByCount "0" @default.
- W2332491362 crossrefType "journal-article" @default.
- W2332491362 hasAuthorship W2332491362A5040830222 @default.
- W2332491362 hasAuthorship W2332491362A5041059803 @default.
- W2332491362 hasAuthorship W2332491362A5051072518 @default.
- W2332491362 hasAuthorship W2332491362A5080878492 @default.
- W2332491362 hasAuthorship W2332491362A5086911541 @default.
- W2332491362 hasAuthorship W2332491362A5088771612 @default.
- W2332491362 hasConcept C109159458 @default.
- W2332491362 hasConcept C126322002 @default.
- W2332491362 hasConcept C201750760 @default.
- W2332491362 hasConcept C203014093 @default.
- W2332491362 hasConcept C2776694085 @default.
- W2332491362 hasConcept C2776999253 @default.
- W2332491362 hasConcept C2777701055 @default.
- W2332491362 hasConcept C2778170410 @default.
- W2332491362 hasConcept C2778729363 @default.
- W2332491362 hasConcept C2779282312 @default.
- W2332491362 hasConcept C28328180 @default.
- W2332491362 hasConcept C502942594 @default.
- W2332491362 hasConcept C54355233 @default.
- W2332491362 hasConcept C71924100 @default.
- W2332491362 hasConcept C86803240 @default.
- W2332491362 hasConcept C8891405 @default.
- W2332491362 hasConceptScore W2332491362C109159458 @default.
- W2332491362 hasConceptScore W2332491362C126322002 @default.
- W2332491362 hasConceptScore W2332491362C201750760 @default.
- W2332491362 hasConceptScore W2332491362C203014093 @default.
- W2332491362 hasConceptScore W2332491362C2776694085 @default.
- W2332491362 hasConceptScore W2332491362C2776999253 @default.
- W2332491362 hasConceptScore W2332491362C2777701055 @default.
- W2332491362 hasConceptScore W2332491362C2778170410 @default.
- W2332491362 hasConceptScore W2332491362C2778729363 @default.
- W2332491362 hasConceptScore W2332491362C2779282312 @default.
- W2332491362 hasConceptScore W2332491362C28328180 @default.
- W2332491362 hasConceptScore W2332491362C502942594 @default.
- W2332491362 hasConceptScore W2332491362C54355233 @default.
- W2332491362 hasConceptScore W2332491362C71924100 @default.
- W2332491362 hasConceptScore W2332491362C86803240 @default.
- W2332491362 hasConceptScore W2332491362C8891405 @default.
- W2332491362 hasIssue "4" @default.
- W2332491362 hasLocation W23324913621 @default.
- W2332491362 hasOpenAccess W2332491362 @default.
- W2332491362 hasPrimaryLocation W23324913621 @default.
- W2332491362 hasRelatedWork W1973295077 @default.
- W2332491362 hasRelatedWork W1976808796 @default.
- W2332491362 hasRelatedWork W2009679953 @default.
- W2332491362 hasRelatedWork W2010599732 @default.
- W2332491362 hasRelatedWork W2045662960 @default.
- W2332491362 hasRelatedWork W2086478399 @default.
- W2332491362 hasRelatedWork W2143098972 @default.
- W2332491362 hasRelatedWork W2149784145 @default.
- W2332491362 hasRelatedWork W2169907921 @default.
- W2332491362 hasRelatedWork W2980538731 @default.
- W2332491362 hasVolume "15" @default.
- W2332491362 isParatext "false" @default.
- W2332491362 isRetracted "false" @default.
- W2332491362 magId "2332491362" @default.
- W2332491362 workType "article" @default.